Subscribe to Updates in Accounting & Financial Analysis

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Groups with Peter Culpepper, CPA, MBA

GLG clusters experts with similar professional backgrounds (based on industry expertise, experience level, job function, geography and others) into ‘Study Groups’.


Peter Culpepper, CPA, MBA
Study Group Name Members
Biopharmaceutical Financial Statement Analysts 31
Biopharmaceuticals Manufacturers (US) 37
Chief Financial Officers 1539
Current or Former Chief Financial Officers in the Pharmaceuticals & Biotechnology Manufacturing and Research Industry 88
Financial Statement Analysts - Leaders, Scholars, and Educators 349
Sarbanes-Oxley Accounting Experts 18
Sarbanes-Oxley Specialists 287
US GAAP Healthcare Specialists 344

Page : 11 to 8 of 8

Analytics


Generated at 2008-09-05T05:45:18.073